Editor(s):

(1) Dr. Begum Rokeya, Dean, Professor& Head, Bangladesh University of Health Sciences, Bangladesh.

Reviewers:

(1) Rosete Nogueira, Universty of Minho, Portugal.

(2) Rosane Malvestiti, Federal University of Santa Catarina, Brazil.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Rosete Nogueira, Portugal) | File 1 | NA

Stage 2 | Peer review report_2 (Rosane Malvestiti, Brazil) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Jongwha Chang, University of Texas, College of Pharmacy, USA.

Reviewers:

(1) Janez Rebol, University Clinical Center Maribor, Slovenia.

(2) Rong-San Jiang, Taichung Veterans General Hospital, Taiwan.

(3) Raphael Richard Ciuman, St. Mary’s Hospital Mülheim An Der Ruhr , Germany.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.66/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Janez Rebol, Slovenia) | File 1 | File 2

Stage 2 | Peer review report_2 (Rong-San Jiang, Taiwan) | File 1 | NA

Stage 2 | Peer review report_3 (Raphael Richard Ciuman, Germany) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Maurice B Silali, Maseno University, Kenya.

(2) Sweta S Koka, Acropolis Institute of Pharmaceutical Education and Research Indore, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Maurice B Silali, Kenya) | File 1 | File 2

Stage 2 | Peer review report_2 (Sweta S Koka, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Chandrashekar K.S, Manipal College of Pharmaceutical Sciences, India.

(2) Amadou Ibrahima Mbaye, Senegal.

(3) Amira Mohammed Beltagy, Damanhour University, Egypt.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.83/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Chandrashekar K.S, India) | File 1 | NA

Stage 2 | Peer review report_2 (Amadou Ibrahima Mbaye, Senegal) | File 1 | File 2

Stage 2 | Peer review report_3 (Amira Mohammed Beltagy, Egypt) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Damineni Saritha, Sultan Ul Uloom College of Pharmacy, India.

(2) Miroshnichenko Ekaterina, Russian Academy of Sciences, Russian.

(3) Fatma hussain, University of Agriculture – UAF, Pakistan.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.66/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Damineni Saritha, India) | File 1 | NA

Stage 2 | Peer review report_2 (Miroshnichenko Ekaterina, Russian) | File 1 | NA

Stage 2 | Peer review report_3 (Fatma hussain, Pakistan) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Takashi Ikeno, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Reviewers:

(1) Satish Dinkarrao Ingale, Pratibha College of Commerce and Computer Studies, Savitribai Phule University Pune, India.

(2) Beatriz Cros Montalbán, Hospital Royo Villanova, Spain.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9.25/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Satish Dinkarrao Ingale, India) | File 1 | NA

Stage 2 | Peer review report_2 (Beatriz Cros Montalbán, Spain) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Giulio Tarro, Professor& President, Foundation T. & L. de Beaumont Bonelli for cancer Research, Napoli, Italy.

Reviewers:

(1) Mercy Gospel Ajuru, Rivers State University, Nigeria.

(2) Sefa Akbulut, Karadeniz Technical University, Turkey.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Mercy Gospel Ajuru, Nigeria) | File 1 | NA

Stage 2 | Peer review report_2 (Sefa Akbulut, Turkey) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Dalong Guo, College of Forestry, Henan University of Science and Technology, People’s Republic of China.

Reviewers:

(1) Salahaddin Abdulqadir Aziz, University Of Sulaimani, Iraq.

(2) Pardeep Kumar, Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Salahaddin Abdulqadir Aziz, Iraq) | File 1 | File 2

Stage 2 | Peer review report_2 (Pardeep Kumar, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. R. Deveswaran, Associate Professor& Head, Drug Design and Development Centre, M.S.Ramaiah University of Applied Sciences, India.

Reviewers:

(1) Preksha Barot, GMERS Medical college, Himmatnagar, India.

(2) Luay Thanoon Younis, Universiti Teknologi MARA (UiTM) Shah Alam, Malaysia.

(3) Tania Mara Pinto Dabés Guimarães, Universidade Federal De Minas Gerais, Brasil.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.6/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Preksha Barot, India) | File 1 | NA

Stage 2 | Peer review report_2 (Luay Thanoon Younis, Malaysia) | File 1 | File 2

Stage 2 | Peer review report_3 (Tania Mara Pinto Dabés Guimarães, Brasil) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Mohamed Fawzy Ramadan Hassanien, Professor, Zagazig University, Zagazig 44519, Egypt.

Reviewers:

(1) Nibu G Philip, Baba Moni Ji Maharaj College of Nursing, India.

(2) Osama Elshazali, University of Khartoum, Sudan.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Nibu G Philip, India) | File 1 | NA

Stage 2 | Peer review report_2 (Osama Elshazali, Sudan) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA